Evidence map›Paper›PMID 41023208›Full record

Trial reportScientific reports2025

Large language models could be applied in personalized out-of-hospital management for breast cancer: a prospective randomized single blind study.

Qinchuan Wang, Zikang Chen, Hao Zhang, Yulu Zhou, Chengyong Du, Wenxian Hu, Xudong Lv, Tan Xie, Heming Zheng

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qinchuan Wang *Department of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China. wangqinchuan@zju.edu.cn.
Zikang Chen *College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, China.
Hao ZhangDepartment of Breast Surgery, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Dalian, Liaoning Province, China.
Yulu ZhouDepartment of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
Chengyong DuDepartment of Breast Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wenxian HuDepartment of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
Xudong LvCollege of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, China.
Tan XieDepartment of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
Heming ZhengDepartment of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Personalized out-of-hospital management could significantly improve quality of life of breast cancer patients. We aimed to evaluate the accuracy, effectiveness, safety, personalization and emotional care of Large Language Models (LLMs) in the out-of-hospital management of breast cancer. We established a data cleaning and classification pipeline to summarize three major scenarios of out-of-hospital management. Authentic electronic health record (EHR) datasets for data collection were generated using 10 patients with ID information masked from Breast Cancer Database in Affiliated Sir Run Run Shaw Hospital, Zhejiang University. Then we matched the EHR datasets with three out-of-hospital management scenarios as 100 virtual patients (VPs) for LLMs to perform the conversation generation using GPT-o3 and DeepSeek-R1. Further, we incorporated four human specialists to rate the responses of LLMs in five dimensions using Likert scale. As of April 1, 2025, the 4 evaluator specialists rated the conversations of LLMs and 100 VPs. The results demonstrate that both DS-R1and GPT-o3 performed well, with scores primarily concentrated at 3 and 4 points. We revealed statistically significant differences between DS-R1and GPT-o3 in accuracy, personalization, and emotional care (P < 0.01). However, the P-values for effectiveness and safety were 0.231 and 0.086. Furthermore, DS-R1generated more tokens (approximately 1.8 times) in identical time with less economic cost, and it also had shorter response time than GPT-o3. GPT-o3 and DS-R1 demonstrated personalized, empathetic, and accurate performance in the out-of-hospital management for breast cancer patients. DS-R1 had better overall performance than GPT-o3, especially in personalization, emotional care and accuracy. More research is warranted in the development specific knowledge embedding LLMs to reduce the detractors like hallucinatory or verbose responses.

Indexed as

Breast NeoplasmsLanguagePrecision MedicineAdultElectronic Health RecordsFemaleHumansLarge Language ModelsMiddle AgedProspective StudiesQuality of LifeSingle-Blind MethodBreast cancerDeepSeek-R1GPT-o3Large language modelsOut-of-hospital management

Identifiers

PMID41023208
PMCPMC12480946

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.